PALO ALTO, Calif., Sept. 16, 2019 /PRNewswire/ -- Varian (NYSE: VAR)
has been recognized again as a leader in the annual IMV
ServiceTrak™ Radiation Oncology Systems report, ranking first in
eight of the tracked categories. Additionally, Varian's Net
Promotor Score improved from 71 in 2018 to 78 in 2019, and again
was the highest among industry competitors. Net Promotor Scores
represents the likelihood a customer would recommend a manufacturer
to a colleague.
"This annual survey is very important to us because it is direct
feedback from our customers," said Chris
Toth, president Varian Oncology Systems. "It is a sign we
are meeting and exceeding their needs and validation we are making
strides in our greater goal of fighting cancer. In addition to
these rankings, we are thrilled the IMV report indicates Varian's
Net Promoter Score continues to improve and be higher than our
industry peers."
Varian ranked first in the following eight Key Performance
Categories:
- Overall manufacturer
- Probability of repurchase
- Technology leadership
- System installation
- Training program
- Overall system performance
- System documentation
- Overall service performance
The IMV ServiceTrak Radiation Oncology Systems report is a
survey of U.S. hospital oncology professionals who perform
therapeutic radiation oncology treatments using external beam
radiation therapy systems. The survey results from interviews with
334 unique radiation therapy sites representing 511 systems.
Interviews were conducted by phone from May to July, 2019.
About Varian
At Varian, we envision a world without
fear of cancer. For more than 70 years, we have developed, built
and delivered innovative cancer care technologies and solutions for
our clinical partners around the globe to help them treat millions
of patients each year. With an Intelligent Cancer Care approach, we
are harnessing advanced technologies like artificial intelligence,
machine learning and data analytics to enhance cancer treatment and
expand access to care. Our 9,200 employees across 70 countries keep
the patient and our clinical partners at the center of our thinking
as we power new victories in cancer care. Because, for cancer
patients everywhere, their fight is our fight. For more
information, visit http://www.varian.com and follow
@VarianMedSys on Twitter.
About IMV
IMV Medical Information Division is a
marketing research and consulting firm founded in 1977,
specializing in medical imaging and other advanced healthcare
technology markets. IMV is part of the Science and Medicine
Group, the leading research and advisory firm serving the life
science, diagnostic and analytical instrument
industries. IMV's market research services, in
combination with its databases of U.S. imaging sites with selected
modalities, provide clients valuable assistance in strategic
planning, customer satisfaction, product development and sales
initiatives.
Press Contact
Mark Plungy
Director, Global Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/varian-ranked-highest-in-survey-of-us-radiation-oncology-professionals-300917642.html
SOURCE Varian